Park Jeong-Yeol, Lee Kyung Hee, Dong Seung Myung, Kang Sokbom, Park Sang-Yoon, Seo Sang-Soo
Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, 809 Madu1-dong, Ilsan-gu, Goyang-si, Gyeonggi-do, 411-351, Korea.
Gynecol Oncol. 2008 Mar;108(3):549-54. doi: 10.1016/j.ygyno.2007.11.009. Epub 2008 Jan 4.
The aim of this study was to evaluate whether the pre-conization high-risk human papilloma virus (HR-HPV) load is predictive for the persistence of HR-HPV infection and the persistence/recurrence of cervical intraepithelial neoplasia (CIN) after conization of the cervix.
A retrospective review was performed on 236 women who underwent conization due to CIN at the Center for Uterine Cancer, National Cancer Center, Korea, between March 2001 and March 2006. The samples for pre-conization HR-HPV test were obtained at least within 3 weeks before conization. All patients underwent HR-HPV testing and cytology between 3 and 6 months after conization, and subsequent follow-up of 3- to 6-month interval was performed thereafter. The persistence of HR-HPV infection and persistence/recurrence of histologic abnormality after conization were analyzed by age, parity, menopausal status, method of conization, glandular extension, margin status, severity of CIN, and pre-cone HR-HPV load in univariate and multivariate analysis.
In univariate analysis, high pre-cone HR-HPV load was the only risk factor for the persistence of HR-HPV infection after conization (persistent HR-HPV infection; 19.8% [23/116] of patients with an HR-HPV load > or = 100 RLU/PC vs. 10.0% [12/120] of patients with a load < 100 RLU/PC, P=0.034). Multivariate analysis showed that an HR-HPV load > or = 100 RLU/PC was a risk factor for persistence/recurrence of histological abnormalities after conization (P=0.040, OR=5.748, 95% CI=1.082-30.526).
Patients with a pre-conization HR-HPV load > or = 100 RLU/PC had a higher rate of persistent HR-HPV infection and a higher rate of persistent/recurrent histological abnormalities after conization for CIN compared to patients with a load < 100 RLU/PC.
本研究旨在评估宫颈锥切术前高危型人乳头瘤病毒(HR-HPV)载量是否可预测锥切术后HR-HPV感染的持续情况以及宫颈上皮内瘤变(CIN)的持续/复发情况。
对2001年3月至2006年3月期间在韩国国立癌症中心子宫癌中心因CIN接受锥切术的236名女性进行回顾性研究。锥切术前HR-HPV检测样本至少在锥切术前3周采集。所有患者在锥切术后3至6个月接受HR-HPV检测和细胞学检查,此后每隔3至6个月进行后续随访。通过年龄、产次、绝经状态、锥切方法、腺体累及情况、切缘状态、CIN严重程度以及锥切术前HR-HPV载量,对锥切术后HR-HPV感染的持续情况以及组织学异常的持续/复发情况进行单因素和多因素分析。
在单因素分析中,锥切术前HR-HPV载量高是锥切术后HR-HPV感染持续的唯一危险因素(持续HR-HPV感染;HR-HPV载量≥100 RLU/PC的患者中为19.8%[23/116],而载量<100 RLU/PC的患者中为10.0%[12/120],P=0.034)。多因素分析显示,HR-HPV载量≥100 RLU/PC是锥切术后组织学异常持续/复发的危险因素(P=0.040,OR=5.748,95%CI=1.082-30.526)。
与HR-HPV载量<100 RLU/PC的患者相比,锥切术前HR-HPV载量≥100 RLU/PC的患者在CIN锥切术后持续HR-HPV感染的发生率更高,组织学异常持续/复发的发生率也更高。